• ABOUT
    • ABOUT US
    • EXECUTIVE LEADERSHIP
    • PROFESSIONAL MANAGEMENT
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORY BOARD
  • Technology
    • PLEX PLATFORM
    • PARTNERSHIP
    • MANUFACTURING FACILITY
    • SCIENTIFIC PUBLICATIONS
  • PIPELINE
    • PLEX PLATFORM PIPELINE
    • PREVENTION OF SSIs
    • D-PLEX100 EFFICACY
    • ABOUT D-PLEX100
    • CLINICAL TRIALS
    • CANCER RESEARCH PROGRAM
    • PAIN RESEARCH PROGRAM
  • INVESTORS
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
    • FINANCIAL INFORMATION
    • CORPORATE GOVERNANCE
    • ANALYST COVERAGE
    • SHARE INFORMATION
    • SHAREHOLDER SERVICES
  • CONTACT
    • CONTACT US
    • CAREERS

ESCP 2022 310 study presented abstract FINAL

ESCP 2022 310 study presented abstract FINAL

ESCP 2022 310 study presented abstract FINAL

PolyPid Ltd. (Headquarters)

18 Hasivim Street, P.O Box 7126
Petach Tikva, Israel 4917002

Phone: +972-74-719-5700

PolyPid Inc.

372 Franklin Ave.
P.O. Box 558
Nutley NJ 07110
Phone: (908) 858-5995

General Information: info@polypid.com

Business Development: BD@polypid.com

  • HOME
  • ABOUT
  • PIPELINE
  • TECHNOLOGY
  • INVESTORS
  • CONTACT
  • ABOUT US
  • PLEX PLATFORM PIPELINE
  • ABOUT D-PLEX
  • CLINICAL TRIALS
  • PLEX PLATFORM
  • CANCER RESEARCH PROGRAM
  • MANUFACTURING FACILITY
  • PARTNERSHIP
© All rights reserved to POLYPID 2015
  • Privacy Policy​
  • CCPA Notice​
  • Site map
UX, UI, Web Development